Suzanne Allan

751 total citations
4 papers, 64 citations indexed

About

Suzanne Allan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Suzanne Allan has authored 4 papers receiving a total of 64 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Suzanne Allan's work include Cancer Genomics and Diagnostics (1 paper), TGF-β signaling in diseases (1 paper) and Cell death mechanisms and regulation (1 paper). Suzanne Allan is often cited by papers focused on Cancer Genomics and Diagnostics (1 paper), TGF-β signaling in diseases (1 paper) and Cell death mechanisms and regulation (1 paper). Suzanne Allan collaborates with scholars based in United Kingdom, United States and Australia. Suzanne Allan's co-authors include Kiruthikah Thillai, Simon Chowdhury, Sarah Rudman, Thomas Powles, Paul R. Jamieson, Brent A. Reynolds, Bryan W. Day, Sara Charmsaz, Kathleen S. Ensbey and Christopher L. Brown and has published in prestigious journals such as Journal of Clinical Oncology, Neuro-Oncology and Expert Review of Anticancer Therapy.

In The Last Decade

Suzanne Allan

4 papers receiving 64 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suzanne Allan United Kingdom	4	38	29	18	17	12	4	64
Yuexin Chen China	4	65 1.7×	30 1.0×	11 0.6×	17 1.0×	10 0.8×	7	86
Mohamed Elfagieh Libya	4	25 0.7×	30 1.0×	10 0.6×	19 1.1×	9 0.8×	9	64
Eugenia Ortega Spain	6	42 1.1×	44 1.5×	25 1.4×	36 2.1×	10 0.8×	9	114
Alexander Andreev-Drakhlin United States	4	20 0.5×	32 1.1×	23 1.3×	13 0.8×	11 0.9×	10	68
Keren Isaev Canada	4	67 1.8×	16 0.6×	12 0.7×	28 1.6×	7 0.6×	7	90
Youstina Hanna Canada	3	36 0.9×	39 1.3×	15 0.8×	36 2.1×	13 1.1×	3	88
Ezgi Karaesmen United States	2	43 1.1×	23 0.8×	35 1.9×	34 2.0×	10 0.8×	3	84
Sebastian Walpole Australia	6	59 1.6×	58 2.0×	14 0.8×	11 0.6×	16 1.3×	7	118
Katayoon Kasaian Canada	2	29 0.8×	25 0.9×	5 0.3×	16 0.9×	10 0.8×	2	70
Natalie J. Kurganovs Australia	6	43 1.1×	23 0.8×	25 1.4×	32 1.9×	5 0.4×	9	93

Countries citing papers authored by Suzanne Allan

Since Specialization

Citations

This map shows the geographic impact of Suzanne Allan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Allan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Allan more than expected).

Fields of papers citing papers by Suzanne Allan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Allan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Allan. The network helps show where Suzanne Allan may publish in the future.

Co-authorship network of co-authors of Suzanne Allan

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Allan. A scholar is included among the top collaborators of Suzanne Allan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Allan. Suzanne Allan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Strauss, Julius, Fadi S. Braiteh, Emiliano Calvo, et al.. (2021). Evaluation of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in cervical cancer: Data from phase 1 and phase 2 studies.. Journal of Clinical Oncology. 39(15_suppl). 5509–5509. 13 indexed citations

2.

Thillai, Kiruthikah, Suzanne Allan, Thomas Powles, Sarah Rudman, & Simon Chowdhury. (2012). Neoadjuvant and adjuvant treatment of renal cell carcinoma. Expert Review of Anticancer Therapy. 12(6). 765–776. 16 indexed citations

3.

Omlin, Aurelius, James Spicer, Debashis Sarker, et al.. (2012). A pharmacokinetic (PK) pharmacodynamic (PD) driven first-in-human study of the oral class I PI3K inhibitor CH5132799, in patients with advanced solid tumors.. Journal of Clinical Oncology. 30(15_suppl). 3022–3022. 4 indexed citations

4.

Day, Bryan W., Brett W. Stringer, Mark Spanevello, et al.. (2011). ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1. Neuro-Oncology. 13(11). 1202–1212. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact